Similar defects ID'd for T2DM, chronic pancreatitis and diabetes

August 2, 2017

(HealthDay)—Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia, according to a study published online July 27 in Diabetes Care.

Lena Mumme, from St. Josef Hospital in Bochum, Germany, and colleagues compared 10 patients with secondary to with 13 patients with type 2 diabetes and 10 healthy controls. Participants underwent stepwise hypoglycemic clamp and an test (OGTT).

The researchers found that patients with diabetes and chronic pancreatitis had higher glucose levels during the OGTT, while levels were lower in controls (P < 0.0001). In both groups with diabetes, insulin and C-peptide levels were reduced, and glucose-induced suppression of glucagon was impaired (all P < 0.0001 versus controls). In patients with chronic pancreatitis and with type 2 diabetes, glucagon concentrations were reduced during hypoglycemia (P < 0.05). There was an inverse relationship between the increase in glucagon during the clamp and the glucose-induced glucagon suppression, and a positive relationship with β-cell function. In patients with type 2 diabetes, but not those with chronic pancreatitis, growth hormone responses to hypoglycemia were lower (P = 0.0002).

"α-cell responses to oral glucose ingestion and to hypoglycemia are disturbed in patients with diabetes and chronic pancreatitis and in patients with type 2 diabetes," the authors write. "The similarities between these defects suggest a common etiology."

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Intense interval training cuts hypoglycemia awareness in T1DM

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Intense interval training cuts hypoglycemia awareness in T1DM

May 2, 2017
(HealthDay)—For patients with type 1 diabetes and normal awareness of hypoglycemia (NAH), high-intensity interval training (HIIT) is associated with reduced awareness of subsequent hypoglycemia, according to a study published ...

Lowest glucose variability for insulin + GLP-1 RA in T2DM

December 20, 2016
(HealthDay)—For patients with type 2 diabetes, the lowest glucose variability (GV) and hypoglycemia is seen for patients using basal insulin + glucagon-like peptide 1 receptor agonist (GLP-1 RA) (BGLP), according to a study ...

Low-carb diet cuts tx effect of glucagon in hypoglycemia

November 7, 2016
(HealthDay)—For patients with type 1 diabetes, a low-carbohydrate diet (LCD) results in lower incremental rises in plasma glucose (PG) after mild hypoglycemia compared with an isocaloric high-carbohydrate diet (HCD), according ...

Gastric bypass cuts hormonal responses to hypoglycemia

June 29, 2016
(HealthDay)—Gastric bypass (GBP) surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published online June 16 in Diabetes.

G-pen may aid hypoglycemia with type 1 diabetes

February 22, 2016
(HealthDay)—Mini-dose glucagon administered using a stable, ready-to-use G-Pen Mini glucagon may be an effective option for mild to moderate hypoglycemia in adults with type 1 diabetes, according to a study published online ...

Progression of dysglycemia in youth similar to adults

July 12, 2014
(HealthDay)—For obese adolescents, glucose sensitivity deteriorates progressively across the spectrum of glucose tolerance, according to a study published online June 19 in Diabetes.

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.